We are committed to the R&D and application of Antimicrobial peptides, EGF, TFF and other peptide bioactive substances, and strive to fundamentally solve the intestinal problems associated with animal growth.
Rota adheres to the concept of utilizing modern life science principles to upgrade traditional farming techniques, gradually realizes the corporate vision of reshaping the foundation of animal health.
-Upgrading traditional breeding
techniques
-Modern life science principles
-Reshaping animal health
foundation
Rota has explored the independent research and development model with synthetic biology and biological "omics" as the core technology, explored the gene engineering technology for the efficient expression of polypeptide genes, formed the gene engineering strain repository with thousands of strains, established the biological activity detection method system of biological molecules, and has more than 20 patents.
Through independent research and development, Rota has developed defensin, epidermal growth factor, trefoil peptide, interleukin-22 and other gene products related to intestinal health, thereby compensating for the lack of endogenous substances required for animal growth in intensive farming.
Rota has formed product launch lines with scientific research institutions, clients and life sciences companies. We have separate research sections for core technology research, technical theoretical model building and product application research, respectively, and are gradually building a bioengineering research center that integrates scientific research, product development and practical applications.
Here can be traced back to some theoretical research, and The FAQ may have the answers you need.